TITLE

Type 1 diabetes: pathogenesis and prevention

AUTHOR(S)
Gillespie, Kathleen M.
PUB. DATE
July 2006
SOURCE
CMAJ: Canadian Medical Association Journal;7/18/2006, Vol. 175 Issue 2, p165
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Type 1 diabetes results from the autoimmune destruction of insulin-producing β cells in the pancreas. Genetic and, as yet undefined, environmental factors act together to precipitate the disease. The excess mortality associated with the complications of type 1 diabetes and the increasing incidence of childhood type 1 diabetes emphasize the importance of therapeutic strategies to prevent this chronic disorder. Why is it considered that type 1 diabetes might be preventable? Different strands of diabetes research are coming together to suggest therapeutic targets. Islet cell auto-antibody assays make it possible to accurately identify people at risk of future disease. In most cases, a long prodrome provides a window of opportunity to reverse the autoimmune process. Although no current "cure" exists, recent genetic data and preliminary trial results suggest T cells as a target for preventive strategies. Another potentially attainable target is induction of tolerance to the β-cell proteins such as insulin that are inappropriately recognized. Other strategies involve β-cell replacement, but currently there are insufficient donor cells available. This may be overcome as the processes controlling the differentiation of pancreatic and nonpancreatic progenitors as well as replication of existing islet β cells are unravelled.
ACCESSION #
21678369

 

Related Articles

  • Insulin as a primary autoantigen for type 1A diabetes. Jasinski, J. M.; Eisenbarth, G. S. // Clinical & Developmental Immunology;Sep2005, Vol. 12 Issue 3, p181 

    Type 1A diabetes mellitus is caused by specific and progressive autoimmune destruction of the beta cells in the islets of Langerhans whereas the other cell types in the islet (alpha, delta, and PP) are spared. The autoantigens of Type 1A diabetes may be divided into subgroups based on their...

  • The Devil We Know. Butterfield, Deb // Diabetes Health;Jul2004, Vol. 13 Issue 7, p11 

    Focuses on several health issues. Autoimmune attack in type 1 diabetes; Information on the beta-cell replacement therapy used for treating diabetes; Discussion on the Edmonton protocol for islet transplantation.

  • T-Cell Responses to Islet Antigens Improves Detection of Autoimmune Diabetes and Identifies Patients With More Severe β-Cell Lesions in Phenotypic Type 2 Diabetes. Goel, Amit; Chiu, Harvey; Felton, Jamie; Palmer, Jerry P.; Brooks-Worrell, Barbara // Diabetes;Aug2007, Vol. 56 Issue 8, p2210 

    Latent autoimmune diabetes in adults or type 1.5 diabetes is considered to be a T-cell-mediated autoimmune disease. However, identification of patients is based commonly on autoantibody (Ab) detection. To determine whether measuring T-cell reactivity to islet proteins compared with measuring Abs...

  • Flow Cytometric Studies of Islet Cell Numbers and Mitotic Activity During Beta Cell-Specific Autoimmunity and Diabetes Development. Pechhold, Klaus; Zhu, Xiaolong; Lee, Janet; Liu, Eric; Harlan, David M. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA427 

    Type 1 diabetes occurs when autoreactive T cells have destroyed most pancreatic insulin-producing beta cells. Current data suggests that in both rodent models and in Man, T cell-mediated diabetes is primarily beta cell antigen-specific, and yet the fate of non-beta cells during the immunological...

  • EXPLORING THE ANTIGENIC SPECIFICITIES OF CD8[sup +] T CELLS INVOLVED IN THE EARLY PATHOGENEICS OF AUTOIMMUNE DIABETES. Lieberman, S.M.; DiLorenzon, T.P. // Einstein Quarterly: Journal of Biology & Medicine;2002, Vol. 19 Issue 4, p184 

    T cell infiltration of pancreatic islets followed by the selective destruction of pancreatic islet β cells characterizes autoimmune diabetes. In the nonobese diabetic (NOD) mouse model of autoimmune diabetes, a model that shares several characteristics with the human disease, both CD8[sup +]...

  • Extracellular Matrix Components Protect Human Beta Cells Against Cell Death. Cechin, Sirlene R.; Gonzalez-Quintana, Jorge; Ochoa, Maria Sofia; Perez-Alvarez, Ingrid; Ichii, Hirohito; Ricordi, Camillo; Inverardi, Luca; Fenjves, Elizabeth // Diabetes;Jun2007 Supplement 1, Vol. 56, pA410 

    Type I diabetes is an autoimmune disease resulting in loss of the insulinproducing beta cells. Islet transplantation can reestablish regulated insulin secretion in patients with type I diabetes but the shortage of islets limits this approach. Enzymatic digestion during islet isolation is poorly...

  • Molecular Basis of Islet Regeneration in NOD Mice Following Adjuvant Treatment. Huszarik, Katrina L.; Krougly, Olga; Singh, Bhagirath // Diabetes;Jun2007 Supplement 1, Vol. 56, pA418 

    Type 1 Diabetes (T1D) is characterized by autoimmune destruction of the insulin producing beta cells in the pancreatic islets. Our previous studies have shown that treatment with complete Freund's adjuvant (CFA) prevents diabetes and islet destruction in NOD mice by downregulating and/or...

  • The Human Pancreatic Islet Transcriptome: Expression of Candidate Genes for Type 1 Diabetes and the Impact of Pro-Inflammatory Cytokines. Eizirik, Décio L.; Sammeth, Michael; Bouckenooghe, Thomas; Bottu, Guy; Sisino, Giorgia; Igoillo-Esteve, Mariana; Ortis, Fernanda; Santin, Izortze; Colli, Maikel L.; Barthson, Jenny; Bouwens, Luc; Hughes, Linda; Gregory, Lorna; Lunter, Gerton; Marselli, Lorella; Marchetti, Piero; McCarthy, Mark I.; Cnop, Miriam // PLoS Genetics;Mar2012, Vol. 8 Issue 3, Special section p1 

    Type 1 diabetes (T1D) is an autoimmune disease in which pancreatic beta cells are killed by infiltrating immune cells and by cytokines released by these cells. Signaling events occurring in the pancreatic beta cells are decisive for their survival or death in diabetes. We have used RNA...

  • Signs of ß-Cell Autoimmunity in Nondiabetic Schoolchildren. Kondrashova, Anita; Viskari, Hanna; Kulmala, Petri; Romanov, Anatolij; Ilonen, Jorma; Hyöty, Heikki; Knip, Mikael // Diabetes Care;Jan2007, Vol. 30 Issue 1, p95 

    OBJECTIVE -- We sought to study the prevalence of autoantibodies to various islet cell antigens in the background population of two neighboring countries with a sixfold difference in the incidence of type 1 diabetes. RESEARCH DESIGN AND METHODS -- Serum samples were obtained from 3,652...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics